Given its pivotal role in lipid metabolism, PCSK9 has emerged as an attractive therapeutic target for managing hypercholesterolemia, liver diseases, and associated cardiovascular conditions. This evidence concerns the gene PCSK9 and familial hypercholesterolemia.